Avenue Therapeutics Inc. (ATXI)
Market Open
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 43
0
0%
$
1.42M Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
-0.97 Eps
$ 0.43
Previous Close Want to track ATXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avenue Therapeutics Inc. (ATXI) Statistics
Valuation metrics
Market Cap 1.42M
Enterprise value -525.16K
Trailing P/E (ttm) -0.51
Forward P/E -0.17
PEG ratio 0
Price/Sales (ttm) 0.91
Price/Book (mrq) 2.49
Enterprise Value/Revenue -0.81
Enterprise Value/EBITDA 0.17
Overview
Shares outstanding 3.18M
Float 2.85M
Shares short 59.7K
% Held by insiders 0.21%
% Held by institutions 0.07%
Average volume (10 days) 1.49K
Average volume (90 days) 5.88K
Price summary
52-Week low 0.15
52-Week high 0.97
Beta -0.92
50-Day moving average 0.49
200-Day moving average 0.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:75
Last split Date 26 Apr 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.25%
Operating margin -1.49%
Operational effectiveness
Return on assets -1.41%
Return on equity -1.55%
Income Statement
Revenue (ttm) 1.4M
Revenue per share (ttm) 0.43
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 1.4M
EBITDA -
Net income to common (ttm) -2.91M
Diluted EPS (ttm) -0.84
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.85M
Total cash per share (mrq) 0.59
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.38%
Book value per share (mrq) 0.17
Cash Flow
Cash flow statement -1.83M
Levered free cash flow (LFCF) -1.1M
2026 © Marketlog. All Rights Reserved.
